Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience

BACKGROUND: In Japan, genetic testing, surveillance, and risk-reducing surgery for hereditary breast and ovarian cancer (HBOC) syndrome have been covered by the Japanese national insurance system since April 2020. On the other hand, the current situation is that medical care, including surveillance...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Aya, Matsumoto, Megumi, Takao, Mami, Miura, Shoko, Hasegawa, Yuri, Otsubo, Ryota, Hayashi, Hiroko, Isomoto, Ichiro, Miura, Kiyonori, Nagayasu, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644634/
https://www.ncbi.nlm.nih.gov/pubmed/37957733
http://dx.doi.org/10.1186/s13053-023-00268-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644634/
https://www.ncbi.nlm.nih.gov/pubmed/37957733
http://dx.doi.org/10.1186/s13053-023-00268-y

Ejemplares similares